The company's low P/E ratio reflects its poor earnings perfo...
The company's low P/E ratio reflects its poor earnings performance and the market's limited growth expectations. Despite the market's projected 41% growth next year, investors don't see enough potential for earnings improvement to justify a higher P/E ratio.
Little Excitement Around Anhui Fengyuan Pharmaceutical Co., Ltd.'s (SZSE:000153) Earnings As Shares Take 26% Pounding
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment